Normal cerebrospinal fluid levels of insulin in patients with Parkinson's disease

被引:12
|
作者
Jiménez-Jiménez, FJ
Molina, JA
Vargas, C
Gómez, P
de Bustos, F
Zurdo, M
Gómez-Escalonilla, C
Barcenilla, B
Berbel, A
Camacho, A
Arenas, J
机构
[1] Univ Madrid, Hosp 12 Octubre, Dept Neurol, Madrid, Spain
[2] Univ Madrid, Hosp 12 Octubre, Dept Biochem, Madrid, Spain
[3] Univ Alcala de Henares, Dept Med Neurol, Alcala De Henares, Spain
关键词
Parkinson's disease; insulin; cerebrospinal fluid levels;
D O I
10.1007/s007020070086
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We compared CSF levels insulin, measured by a Radioimmunoanalysis method, in 24 patients with Parkinson's disease (PD) and 21 matched controls. The CSF insulin levels did not differ significantly between PD patients and controls. CSF insulin levels were not correlated with age, age at onset, duration of the disease, scores of the Unified Parkinson Disease Rating Scale of the Hoehn and Yahr staging in the PD group. Antiparkinsonian therapy did not influence significantly and CSF levels of insulin. These results suggest that CSF insulin concentrations are not a biological marker of PD and its severity.
引用
收藏
页码:445 / 449
页数:5
相关论文
共 50 条
  • [41] Dynamic Changes of Anandamide in the Cerebrospinal Fluid of Parkinson's Disease Patients
    Pisani, Valerio
    Moschella, Vincenzo
    Bari, Monica
    Fezza, Filomena
    Galati, Salvatore
    Bernardi, Giorgio
    Stanzione, Paolo
    Pisani, Antonio
    Maccarrone, Mauro
    MOVEMENT DISORDERS, 2010, 25 (07) : 920 - 924
  • [42] Cerebrospinal fluid levels of phosphotau in patients with Alzheimer's disease
    Sakka, P
    Nikolaou, C
    Lymperopoulou, O
    Efthymiou, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S299 - S299
  • [43] Cerebrospinal fluid levels of selenium in patients with Alzheimer's disease
    I. Meseguer
    J. A. Molina
    F. J. Jiménez-Jiménez
    M. V. Aguilar
    C. J. Mateos-Vega
    M. J. González-Muñoz
    F. de Bustos
    M. Ortí-Pareja
    M. Zurdo
    A. Berbel
    E. Barrios
    M. C. Martínez-Para
    Journal of Neural Transmission, 1999, 106 : 309 - 315
  • [44] Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease
    Molina, JA
    Jiménez-Jiménez, FJ
    Hernánz, A
    Fernández-Vivancos, E
    Medina, S
    de Bustos, F
    Gómez-Escalonilla, C
    Sayed, Y
    JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (7-8) : 1035 - 1044
  • [45] Insulin Levels are Decreased in the Cerebrospinal Fluid of Women with Prodomal Alzheimer's Disease
    Gil-Bea, Francisco J.
    Solas, Maite
    Solomon, Alina
    Mugueta, Carmen
    Winblad, Bengt
    Kivipelto, Miia
    Ramirez, Maria J.
    Cedazo-Minguez, Angel
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (02) : 405 - 413
  • [46] Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease
    Barschke, Peggy
    Abu-Rumeileh, Samir
    Al Shweiki, M. H. D. Rami
    Barba, Lorenzo
    Paoletti, Federico Paolini
    Oeckl, Patrick
    Steinacker, Petra
    Halbgebauer, Steffen
    Gaetani, Lorenzo
    Lewerenz, Jan
    Ludolph, Albert Christian
    Landwehrmeyer, Georg Bernhard
    Parnetti, Lucilla
    Otto, Markus
    JOURNAL OF NEUROLOGY, 2022, 269 (09) : 5136 - 5143
  • [47] Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease
    Meier, A
    Mollenhauer, B
    Cohrs, S
    Rodenbeck, A
    Jordan, W
    Meller, J
    Otto, M
    BRAIN RESEARCH, 2005, 1063 (02) : 201 - 203
  • [48] Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington’s and Parkinson’s disease
    Peggy Barschke
    Samir Abu-Rumeileh
    M. H. D. Rami Al Shweiki
    Lorenzo Barba
    Federico Paolini Paoletti
    Patrick Oeckl
    Petra Steinacker
    Steffen Halbgebauer
    Lorenzo Gaetani
    Jan Lewerenz
    Albert Christian Ludolph
    Georg Bernhard Landwehrmeyer
    Lucilla Parnetti
    Markus Otto
    Journal of Neurology, 2022, 269 : 5136 - 5143
  • [49] Serum and cerebrospinal fluid urate levels in Parkinson's disease and atypical parkinsonian disorders
    Constantinescu, R.
    Andreasson, U.
    Holmberg, B.
    Zetterberg, H.
    MOVEMENT DISORDERS, 2010, 25 (07) : S496 - S496
  • [50] APP processing genes and cerebrospinal fluid biomarker levels in Parkinson's disease dementia
    Bekris, L. M.
    Lutz, F.
    Millard, S.
    Debby, T. W.
    Elaine, P. R.
    Chang, Y. E.
    Thomas, M. J.
    Jing, Z.
    Cyrus, Z.
    James, L. B.
    MOVEMENT DISORDERS, 2013, 28 : S408 - S408